Resumo

AMARU CALZADA, Ariel et al. FREQUENCY OF P210 BCR-ABL TRANSCRIPTS IN 272 BOLIVIAN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML). Rev. Méd. La Paz [online]. 2016, vol.22, n.1, pp.13-19. ISSN 1726-8958.

There are two main forms of BCR/ABL fusion gene, involving exon 2 of ABL gene and different exons of the BCR gene, the transcripts b2a2 or b3a2 code for a p210 protein, and the transcript e1a2 code a p190 protein. In Bolivia, there is no information about the frequency of these isoforms of chimeric gene BCR/ABL in chronic myeloid leukemia (CML). The present study was designed to determine the frequency of co-expression of p210 transcripts in 272 patients with CML. It was conducted reverse transcriptase polymerase chain reaction (RT-PCR) tests in samples of bone marrow and peripheral blood of adult and pediatric patients with CML diagnosis, positive for some kind of BCR/ABL rearrangement. The transcript b2a2 was found in 96 (35,3%) patients; and b3a2 transcript in 154 (56.6%) cases; whereas, in 22 (8.1%) patients both transcripts were detected. Survival analysis was performed, it was observed that to 5 years the overall survival (OS) was 64%, and the progression free survival (PFS) was 42%. It was also observed that the type of transcript does not affect OS and PFS. Statistical analysis of our study, displayed no significant differences in the expression of different transcripts BCR/ABL of the Bolivian population, in relation to studies reported in other populations.

Palavras-chave : BCR-ABL; LMC; p210; Bolivia; Survival rate.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )